Publication | Open Access
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma
41
Citations
19
References
2018
Year
Pilot TrialCancer ImmunosurveillanceMedicineMelanomaImmunologyHu14.18-il2 ImmunocytokineDermatologyStage Iv MelanomaImmunotherapyOncologyCancer ResearchSkin Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1